We also used immunofluorescence to determine the effects of CXCL1 on SOX4 signaling, and found that after CXCL1 treatment, SOX4 expression significantly increased in the nucleus of both breast cancer cell lines (Fig. 4b). The gene discussed is CXCL1; the disease is breast carcinoma.